EARNING RECAP

Restoration Hardware

#RH 2019 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q1 adj. EPS $1.85, consensus $1.55 $598.42M, consensus $584.25M +15.83% ($109.91 closing price) $121.75 $109.71 raises FY19 adj. EPS view to $8.76-$9.27 from $8.05-$8.69, consensus $8.40 Raises FY19 revenue view to $2.64B-$2.66B from $2.59B-$2.64B est. $2.61B.
#RH 2018 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q4 adjusted $3 est. $2.85 $670.9M est. $686.6M -21.97% ($102.95 closing price0 $114.50 $102.19 sees FY19 EPS $8.41- $9.09 est. $10.13; sees FY19 revenue $2.585B -$2.635B est. $2.76B; Q4 operating margin 15.9% vs: 11.2% last year; says will no longer report comps moving forward
Q3 $1.73 est. $1.27 $636.6M est. $632.18M +10.90% ($137.13 closing price) $148.54 $132.33 raises Q4 EPS & revenue to $2.75- $2.90 from $2.33- $2.54, est. $2.50; $680M -$690M from $665M -$685M, est $679.35M; raises Fy18 EPS view to $8.33- $8.47; Q3 adjusted operating margin at 10.3% vs. 8.1% last year
Q2 adjusted $2.49 est. $1.75 $640.8M est. $660.89M -13.07% ($131.51 closing price) $147.25 $130.12 raises Q3 adjusted EPS view to $7.35- $7.75 from $6.34- $6.83 est. $6.71
Q1 adjusted $1.33 est. $1.02 $557.4M est. $563.16M +30.55% ($155 closing price) $164.49 $142.47 Record high. Raises FY18 view to $6.34- $6.83 from $5.45 -$6.20 est. %5.91; Revenue $2.53B -$2.57B est.$2.55B; Gross Margin 39.3% -39.6%
#RH 2017 EPS:(Actual vs Estimate) Revenue(Actual vs Estimate) Stock price move next bell High Low Notes
Q4 $1.69 est. $1.55 $670.3M est. $672.61M +22.48% ($92.24 closing price) $94.8 $86.26 sees Q1 adj. EPS 95c -$1.05 est. 58c, cuts Fy18 revenue vie $2.53B-$2.57B -from $2.58B-$2.62Best. $2.6B
Q3 adjusted $1.04 est. $1.04 $592.47M est. $591M +.79% ($104.7 closing price) $109.53 $95.5 sees Q4 rev. $655M-$680M est. $673.53M,backs FY 17 revenue $2.58B-$2.62B est. $2.6B
Q2 65c est. 47c $615.3M est. $606.36M +.80% (104.70 closing price) 109.53 95.50 guides Q3 adjusted 68-80c est. 40c; revenue $575M-$595M est. $59878M

Please select phase first
Disclaimer! This is NOT an investment advice. The data result herein is purely speculation only. You must do your own due diligence and mitigate your risk. You acknowledge that TradersFish.com will not be held responsible and accountable for any losses you may incur using our Biotech Data Calculator. Please consult your own financial adviser before executing trades.